NCT05611892View on ClinicalTrials.gov

Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

December 22, 2022

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2027

Conditions
Enterobacterial InfectionsOncologic DiseaseInflammatory DiseaseInvasive Fungal Infections
Interventions
COMBINATION_PRODUCT

18F-FDS PET/CT

20 millicurie (mCi) of 18F-FDS in adult patient age group and 2.5 mCi in children (age 12-18 years old) followed by a PET/CT scan.

Trial Locations (1)

21218

RECRUITING

Johns Hopkins Medical Institutions, Baltimore

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Johns Hopkins University

OTHER